LAUSANNE, Switzerland, March 3, 2026 /PRNewswire/ — Xsensio SA, a Swiss deep-tech company pioneering near real-time continuous biochemical monitoring, today…
Read More
First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to Type 2 diabetes (T2D) management Hong Kong…
Read More
Business Wire India 3650 Capital (“3650”), a nationwide alternative commercial real estate lender, special servicer and solutions provider focused on…
Read More